Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats

Cardiovascular Diabetology

Volumn 7, Issue , 2008, Pages

  Shehata, Marlene F ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 27; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE 7; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SELENOPROTEIN; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DISEASE MODEL; ENVIRONMENTAL FACTOR; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEREDITY; HIGH SODIUM INTAKE; HYPOTHESIS; INFLAMMATION; INSULIN RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; GENE EXPRESSION REGULATION; GENETICS; HYPERTENSION; METABOLISM; PHENOTYPE; PHYSIOLOGY; SALT INTAKE;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; HYPERTENSION; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MAP KINASE KINASE 4; PHENOTYPE; RATS; RATS, INBRED DAHL; SIGNAL TRANSDUCTION; SODIUM CHLORIDE, DIETARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 47749084330     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-7-19     Document Type: Article

References (133)

1. DeFronzo RA Ferrannini E Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease Diabetes Care 1991, 14(3):173-194. 10.2337/diacare.14.3.173 2044434
2. Reaven G Role of insulin resistance in human disease Diabetes 1988, 37:1595. 3056758 10.2337/diabetes.37.12.1595
3. Reaven G Insulin Resistance, Hypertension, and Coronary Heart Disease J Clin Hypertens 2003, 5:269. 10.1111/j.1524-6175.2003.01764.x
4. Sievenpiper JL Jenkins AL Whitham DL Vuksan V Insulin resistance: concepts, controversies, and the role of nutrition Can J Diet Pract Res 2002, Spring 63 1 20-32 10.3148/63.1.2002.20
5. Shehata M Genetic and dietary salt contributors to insulinresistance in Dahl salt-sensitive (S) rats Cardiovasc Diabetol 2008, 7:7. 18397529 10.1186/1475-2840-7-7 2365939
6. Ceriello A Motz E Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited Arterioscler Thromb Vasc Biol 2004, 24:816-823. 14976002 10.1161/01.ATV.0000122852.22604.78
7. Hu FB Stampfer MJ Is type 2 diabetes mellitus a vascular condition? Arterioscler Thromb Vasc Biol 2003, 23:1715-1716. 14555640 10.1161/ 01.ATV.0000094360.38911.71
8. Roebuck KA Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review) Int J Mol Med 1999, 4(3):223-230. 10425270
9. Manning RD Jr Meng S Tian N Renal and vascular oxidative stress and salt-sensitivity of arterial pressure Acta Physiol Scand 2003, 179(3):243-250. 10.1046/j.0001-6772.2003.01204.x 14616240
10. Matsui H Shimosawa T Uetake Y Wang H Ogura S Kaneko T Liu J Ando K Fujita T Protective effect of potassium against the hypertensive cardiac dysfunction: Association with reactive oxygen species reduction Hypertension 2006, 48(2):225-231. 10.1161/01.HYP.0000232617.48372.cb 16818802
11. Dobrian AD Schriver SD Lynch T Prewitt RL Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity Am J Physiol Renal Physiol 2003, 285(4):F619-28. 12799306
12. Taylor NE Glocka P Liang M Cowley AWJ NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S Rats Hypertension 2006, 47:692. 16505210 10.1161/ 01.HYP.0000203161.02046.8d
13. Reddy SY Leclerc F Karplus M DNA polymorphism: A comparison of force fields for nucleic acids Biophys J 2003, 84(3):1421-1449. 1302718 12609851
14. Zinchenko AA Yoshikawa K Na+ shows a markedly higher potential than K+ in DNA compaction in a crowded environment Biophys J 2005, 88:4118-4123. 15778438 10.1529/biophysj.104.057323 1305642
15. St Lezin E Simonet L Pravenec M Kurtz TW Hypertensive strains and normotensive 'control' strains. How closely are they related? Hypertension 1992, 19:419-424. 1568758
16. Reaven GM Twersky J Chang H Abnormalities of carbohydrate and lipid metabolism in Dahl rats Hypertension 1991, 18:630-635. 1937666
17. Buchanan TA Sipos GF Gadalah S Yip KP Marsh DJ Hsueh W Bergman RN Glucose tolerance and insulin action in rats with renovascular hypertension Hypertension 1991, 18(3):341-347. 1889847
18. Tomiyama H Kushiro T Abeta H Kurumatani H Taguchi H Kuga N Saito F Kobayashi F Otsuka Y Kanmatsuse K Blood pressure response to hyperinsulinemia in salt-sensitive and salt-resistant rats Hypertension 1992, 20(5):596-600. 1428109
19. Ogihara T Asano T Ando K Sakoda H Anai M Shojima N Ono H Onishi Y Fujishiro M Abe M Fukushima Y Kikuchi M Fujita T High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats Hypertension 2002, 40(1):83-89. 10.1161/01.HYP.0000022880.45113.C9 12105143
20. Sechi LA Griffin CA Zingaro L Catena C De Carli S Schambelan M Bartoli E Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats Am J Hypertens 1997, 10(11):1223-1230. 10.1016/S0895-7061(97)00220-3 9397240
21. Garvey WT Birnbaum MJ Cellular insulin action and insulin resistance Baillieres Clin Endocrinol Metab 1993, 7:785-873. 8304915 10.1016/ S0950-351X(05)80237-X
22. Cheatham B Kahn CR Insulin action and the insulin signaling network Endocr Rev 1995, 16:117-142. 7781591 10.1210/er.16.2.117
23. Sun XJ Rothenberg P Kahn CR Backer JM Araki E Wilden PA Cahill DA Goldstein BJ White MF Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein Nature 1991, 352:73-77. 1648180 10.1038/352073a0
24. Sun XJ Wang LM Zhang Y Yenush L Myers MG Jr Glasheen E Lane WS Pierce JH White MF Role of IRS-2 in insulin and cytokine signaling Nature 1995, 377:173-177. 7675087 10.1038/377173a0
25. Laakso M Malkki M Kekalainen P Kuusisto J Deeb SS Insulin receptor substrate-1 variants in non-insulin-dependent diabetes J Clin Invest 1994, 94:1141-1146. 8083355 10.1172/JCI117429 295183
26. Lavan BE Fantin VR Chang ET Lane WS Keller SR Lienhard GE A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family J Biol Chem 1997, 272(34):21403-21407. 10.1074/jbc.272.34.21403 9261155
27. Paz K Voliovitch H Hadari YR Roberts CT Jr LeRoith D Zick Y Interaction between the insulin receptor and its downstream effectors. Use of individually expressed receptor domains for structure/function analysis J Biol Chem 1996, 271(12):6998-7003. 10.1074/jbc.271.25.15084 8636129
28. Almind K Inoue G Pedersen O Kahn CR A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies J Clin Invest 1996, 97(11):2569-2575. 10.1172/ JCI118705 8647950 507343
29. Berger D Barroso I Soos M Yeo G Schafer AJ O'Rahilly S Whitehead JP Genetic variants of insulin receptor substrate-1 (IRS-1) in syndromes of severe insulin resistance. Functional analysis of Ala513Pro and Gly1158Glu IRS-1 Diabet Med 2002, 19(10):804-809. 10.1046/ j.1464-5491.2002.00779.x 12358865
30. Celi FS Negri C Tanner K Raben N De Pablo F Rovira A Pallardo LF Martin-Vaquero P Stern MP Mitchell BD Shuldiner AR Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with Type 2 diabetes mellitus Diabetes Metab Res Rev 2000, 16(5):370-377. 10.1002/ 1520-7560(2000)9999:9999<::AID-DMRR129>3.0.CO;2-B 11025561
31. Clausen JO Hansen T Bjorbaek C Echwald SM Urhammer SA Rasmussen S Andersen CB Hansen L Almind K Winther K Insulin resistance: Interactions between obesity and a common variant of insulin receptor substrate-1 Lancet 1995, 346(8972):397-402. 10.1016/S0140-6736(95)92779-4 7623569
32. Imai Y Fusco A Suzuki Y Lesniak MA D'Alfonso R Sesti G Bertoli A Lauro R Accili D Taylor SI Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 1994, 79(6):1655-1658. 10.1210/jc.79.6.1655 7989470
33. Le Fur S Le Stunff C Bougneres P Increased insulin resistance in obese children who have both 972 IRS-1 and 1057 IRS-2 polymorphisms Diabetes 2002, 51(Suppl 3):S304-7. 12475767 10.2337/diabetes.51.2007.S304
34. Lei HH Coresh J Shuldiner AR Boerwinkle E Brancati FL Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: The Atherosclerosis Risk in Communities Study Diabetes 1999, 48(9):1868-1872. 10.2337/diabetes.48.9.1868 1048062
35. Mammarella S Creati B Esposito DL Arcuri P Della Loggia F Capani F Mariani-Costantini R Caramia FG Battista P Cama A Novel allele of the insulin receptor substrate-1 bearing two non-conservative amino acid substitutions in a patient with noninsulin-dependent diabetes mellitus. Mutations in brief no. 130. Online Hum Mutat 1998, 11(5):411. 10.1002/ (SICI)1098-1004(1998)11:5<411::AID-HUMU12>3.0.CO;2-# 10206679
36. 't Hart LM Nijpels G Dekker JM Maassen JA Heine RJ van Haeften TW Variations in insulin secretion in carriers of gene variants in IRS-1 and -2 Diabetes 2002, 51(3):884-887. 10.2337/diabetes.51.3.884 11872698
37. Sesti G Federici M Hribal ML Lauro D Sbraccia P Lauro R Defects of the insulin receptor substrate (IRS) system in human metabolic disorders FASEB J 2001, 15(120):2099-2111. 10.1096/fj.01-0009rev 11641236
38. Sun XJ Crimmins DL Myers MG Jr Miralpeix M White MF Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 Mol Cell Biol 1993, 13(12):7418-7428. 364813 7504175
39. Qiao LY Zhande R Jetton TL Zhou G Sun XJ In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents J Biol Chem 2002, 277:26530-26539. 12006586 10.1074/jbc.M201494200
40. Draznin B Molecular mechanisms of insulin resistance: Serine phosphorylation of insulin receptor substrate-1 and increased expression of p85alpha: The two sides of a coin Diabetes 2006, 55(8):2392-2397. 10.2337/db06-0391 16873706
41. Greene MW Sakaue H Wang L Alessi DR Roth RA Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation J Biol Chem 2003, 278(10):8199-8211. 10.1074/ jbc.M209153200 12510059
42. Liu YF Herschkovitz A Boura-Halfon S Ronen D Paz K Leroith D Zick Y Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance Mol Cell Biol 2004, 24(21):9668-9681. 10.1128/ MCB.24.21.9668-9681.2004 15485932 522236
43. Paz K Hemi R LeRoith D Karasik A Elhanany E Kanety H Zick Y A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation J Biol Chem 1997, 272(47):29911-29918. 10.1074/jbc.272.47.29911 9368067
44. Asano T Ogihara T Katagiri H Sakoda H Ono H Fujishiro M Anai M Kurihara H Uchijima Y Glucose transporter and Na+/glucose cotransporter as molecular targets of anti-diabetic drugs Curr Med Chem 2004, 11(20):2717. 15544472
45. Ruiz-Opazo N Cloix JF Melis MG Xiang XH Herrera VL Characterization of a sodium-response transcriptional mechanism Hypertension 1997, 30(2 Pt 1):191-198. 9260979
46. Kitiyakara C Chabrashvili T Chen Y Blau J Karber A Aslam S Welch WJ Wilcox CS Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase J Am Soc Nephrol 2003, 14(11):2775-2782. 10.1097/01.ASN.0000092145.90389.65 14569087
47. Hansen LL Ikeda Y Olsen GS Busch AK Mosthaf L Insulin signaling is inhibited by micromolar concentrations of H(2)O(2). Evidence for a role of H(2)O(2) in tumor necrosis factor alpha-mediated insulin resistance J Biol Chem 1999, 274:25078-25084. 10455187 10.1074/jbc.274.35.25078
48. Rudich A Tirosh A Potashnik R Hemi R Kanety H Bashan N Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes Diabetes 1998, 47(10):1562-1569. 10.2337/diabetes.47.10.1562 9753293
49. Tirosh A Potashnik R Bashan N Rudich A Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation J Biol Chem 1999, 274(15):10595-10602. 10.1074/ jbc.274.15.10595 10187855
50. Talior I Yarkoni M Bashan N Eldar-Finkelman H Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice Am J Physiol Endocrinol Metab 2003, 285(2):E295-302. 12857675
51. Fujita M Ando K Nagae A Fujita T Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension Hypertension 2007, 50(2):360-367. 10.1161/ HYPERTENSIONAHA.107.091009 17576857
52. Gu JW Tian N Shparago M Tan W Bailey AP Manning RD Jr Renal NF-kappaB activation and TNF-alpha upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats Am J Physiol Regul Integr Comp Physiol 2006, 291(6):R1817-24. 16840655
53. Hamaguchi A Kim S Izumi Y Iwao H Chronic activation of glomerular mitogen-activated protein kinases in Dahl salt-sensitive rats J Am Soc Nephrol 2000, 11(1):39-46. 10.1159/000017212 10616838
54. Kanety H Feinstein R Papa MZ Hemi R Karasik A Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1 J Biol Chem 1995, 270(40):23780-23784. 10.1074/ jbc.270.40.23780 7559552
55. Paz K Hemi R LeRoith D Karasik A Elhanany E Kanety H Zick Y A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation J Biol Chem 1997, 272(47):29911-29918. 10.1074/jbc.272.47.29911 9368067
56. Feinstein R Kanety H Papa MZ Lunenfeld B Karasik A Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates J Biol Chem 1993, 268(35):26055-26058. 8253716
57. Aguirre V Uchida T Yenush L Davis R White MF The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307) J Biol Chem 2000, 275(12):9047-9054 10.1074/jbc.275.12.9047 10722755
58. Venkatesha RT Ahamed J Nuesch C Zaidi AK Ali H Platelet-activating factor-induced chemokine gene expression requires NF-kappaB activation and Ca2+/calcineurin signaling pathways. Inhibition by receptor phosphorylation and beta-arrestin recruitment J Biol Chem 2004, 279(43):44606-44612. 10.1074/jbc.M408035200 15308653
59. Kim JK Kim YJ Fillmore JJ Chen Y Moore I Lee J Yuan M Li ZW Karin M Perret P Shoelson SE Shulman GI Prevention of fat-induced insulin resistance by salicylate J Clin Invest 2001, 108(3):437-446. 209353 11489937
60. Yuan M Konstantopoulos N Lee J Hansen L Li ZW Karin M Shoelson SE Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta Science 2001, 293(5535):1673-1677. 10.1126/science.1061620 11533494
61. Wasserman DH Ayala JE Interaction of physiological mechanisms in control of muscle glucose uptake Clin Exp Pharmacol Physiol 2005, 32(4):319-323. 10.1111/j.1440-1681.2005.04191.x 15810999
62. Manchester J Kong X Nerbonne J Lowry OH Lawrence JC Jr Glucose transport and phosphorylation in single cardiac myocytes: Rate-limiting steps in glucose metabolism Am J Physiol 1994, 266(Pt 1):E326-33. 8166252
63. Furler SM Jenkins AB Storlien LH Kraegen EW In vivo location of the rate-limiting step of hexose uptake in muscle and brain tissue of rats Am J Physiol 1991, 261(3 Pt 1):E337-47. 1887881
64. Kubo K Foley JE Rate-limiting steps for insulin-mediated glucose uptake into perfused rat hindlimb Am J Physiol 1986, 250(1 Pt 1):E100-2. 3510557
65. Saavedra JM Del Carmine R McCarty R Guicheney P Weise V Iwai J Increased adrenal catecholamines in salt-sensitive genetically hypertensive Dahl rats Am J Physiol 1983, 245(5 Pt 1):H762-6. 6139026
66. Rizza RA Cryer PE Haymond MW Gerich JE Adrenergic mechanisms of catecholamine action on glucose homeostasis in man Metabolism 1980, 29(11 Suppl 1):1155-1163. 10.1016/0026-0495(80)90025-6 7001182
67. Rizza RA Cryer PE Haymond MW Gerich JE Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man J Clin Invest 1980, 65(3):682-689. 10.1172/JCI109714 6243675 371410
68. Chiasson JL Shikama H Chu DT Exton JH Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle J Clin Invest 1981, 68(3):706-713. 10.1172/JCI110306 6115864 370852
69. James DE Burleigh KM Kraegen EW In vivo glucose metabolism in individual tissues of the rat. Interaction between epinephrine and insulin J Biol Chem 1986, 261(14):6366-6374. 3516993
70. Jensen J Aslesen R Ivy JL Brors O Role of glycogen concentration and epinephrine on glucose uptake in rat epitrochlearis muscle Am J Physiol 1997, 272(4 Pt 1):E649-55. 9142887
71. Jensen J Dahl HA Adrenaline stimulated glycogen breakdown in rat epitrochlearis muscles: Fibre type specificity and relation to phosphorylase transformation Biochem Mol Biol Int 1995, 35(1):145-154. 7735129
72. Richter EA Influence of the sympatho-adrenal system on some metabolic and hormonal responses to exercise in the rat with special reference to the effect on glycogenolysis in skeletal muscle Acta Physiol Scand Suppl 1984, 528:1-42. 6382923
73. Hansen PA Gulve EA Holloszy JO Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle J Appl Physiol 1994, 76(2):979-985. 8175614
74. Lueck JD Fromm HJ Kinetics, mechanism, and regulation of rat skeletal muscle hexokinase J Biol Chem 1974, 249(5):1341-1347. 4594125
75. Challiss RA Lozeman FJ Leighton B Newsholme EA Effects of the beta-adrenoceptor agonist isoprenaline on insulin-sensitivity in soleus muscle of the rat Biochem J 1986, 233(2):377-381. 1153038 3513763
76. Lee AD Hansen PA Schluter J Gulve EA Gao J Holloszy JO Effects of epinephrine on insulin-stimulated glucose uptake and GLUT-4 phosphorylation in muscle Am J Physiol 1997, 273(3 Pt 1):C1082-7. 9316430
77. Young DA Wallberg-Henriksson H Cranshaw J Chen M Holloszy JO Effect of catecholamines on glucose uptake and glycogenolysis in rat skeletal muscle Am J Physiol 1985, 248(5 Pt 1):C406-9. 3993767
78. Wilson JE Brain hexokinase. A proposed relation between soluble-particulate distribution and activity in vivo J Biol Chem 1968, 243(13):3640-3647. 5658541
79. Sechi LA Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity J Hypertens 1999, 17(9);1229-1237. 10.1097/00004872-199917090-00001 10489099
80. Sechi LA Bartoli E Mechanisms of insulin resistance leading to hypertension: What we can learn from experimental models J Investig Med 1997, 45(5):238-251. 9249996
81. Shehata MF Leenen FH Tesson F Sequence analysis of coding and 3′ and 5′ flanking regions of the epithelial sodium channel alpha, beta, and gamma genes in Dahl S versus R rats BMC Genet 2007, 8:35. 17592634 10.1186/1471-2156-8-35 1933436
82. Shehata MF Leenen FHH Tesson F Polymorphisms in 5'UTR of ENaC α, β and γ genes in Dahl and Wistar rats FASEB 2006, 20:A310-A311.
83. Shehata MF Tesson F Leenen FH Are Genetic Variations in the Coding Sequence of ENaC Alpha, Beta and/or Gamma Subunits Associated with Salt Sensitive Hypertension in Dahl Rats? Can J Cardiology 2005, 21:135C.
84. Shehata MF Tesson F Leenen FH Are Genetic Variations in the Coding Sequence of ENaC Alpha, Beta and/or Gamma Subunits Associated with Salt Sensitive Hypertension in Dahl Rats? Second Annual Research Forum for Young Investigators in Circulatory and Respiratory Health 2005
85. Ellis LA Taylor CF Taylor GR A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning Hum Mutat 2000, 15(6):556-564. 10.1002/ 1098-1004(200006)15:6<556::AID-HUMU7>3.0.CO;2-C 10862085
86. Eshleman SH Crutcher G Petrauskene O Kunstman K Cunningham SP Trevino C Davis C Kennedy J Fairman J Foley B Kop J Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer J Clin Microbiol 2005, 43(2):813-817. 10.1128/JCM.43.2.813-817.2005 15695685 548107
87. Shehata M Shehata M Shehata F Pater A Apoptosis effects of Xrel3 c-Rel/ Nuclear Factor-kappa B homolog in human cervical cancer cells Cell Biol Int 2005, 29(6):429-440. 10.1016/j.cellbi.2004.12.014 16054560
88. Shehata M Shehata M Shehata F Pater A Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells Cell Biol Int 2004, 28(12):895-904. 10.1016/j.cellbi.2004.09.002 15566959
89. Shehata MF Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells Cancer Cell Int 2005, 5(1):10. 10.1186/ 1475-2867-5-10 15857509 1090600
90. Shehata MF Tesson F Leenen FH Polymorphisms in 5'UTR of ENaC alpha, beta and gamma genes in Dahl and Wstar rats Third Annual Research Forum for Young Investigators in Circulatory and Respiratory Health 2006
91. Rojas FA Hirata AE Saad MJ Regulation of IRS-2 tyrosine phosphorylation in fasting and diabetes Mol Cell Endocrinol 2001, 183(1-2):63-69. 10.1016/S0303-7207(01)00597-4 11604226
92. Valverde AM Benito M Lorenzo M The brown adipose cell: A model for understanding the molecular mechanisms of insulin resistance Acta Physiol Scand 2005, 183(1):59-73. 10.1111/j.1365-201X.2004.01384.x 15654920
93. Valverde AM Benito M The brown adipose cell: A unique model for understanding the molecular mechanism of insulin resistance Mini Rev Med Chem 2005, 5(3):269-278. 15777261
94. Cengel KA Freund GG JAK1-dependent phosphorylation of insulin receptor substrate-1 (IRS-1) is inhibited by IRS-1 serine phosphorylation J Biol Chem 1999, 274(39):27969-27974. 10.1074/jbc.274.39.27969 10488146
95. Sechi LA Griffin CA Zingaro L Valentin JP Bartoli E Schambelan M Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats Diabetologia 1997, 40(7):770-777. 10.1007/ s001250050748 9243097
96. Risch N Merikangas K The future of genetic studies of complex human diseases Science 1996, 273:1516-1517. 8801636 10.1126/ science.273.5281.1516
97. Stephens M Smith NJ Donnelly P A new statistical method for haplotype reconstruction from population data Am J Hum Genet 2001, 68(4):978-989. 10.1086/319501 11254454 1275651
98. Holmang A Mimura K Bjorntorp P Lonnroth P Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats Diabetes 1997, 46(11):1799-1804. 10.2337/diabetes.46.11.1799 9356029
99. Holmang A Muller M Andersson OK Lonnroth P Minimal influence of blood flow on interstitial glucose and lactate-normal and insulin-resistant muscle Am J Physiol 1998, 274(3 Pt 1):E446-52. 9530127
100. Muller M Holmang A Andersson OK Eichler HG Lonnroth P Measurement of interstitial muscle glucose and lactate concentrations during an oral glucose tolerance test Am J Physiol 1996, 271(6 Pt 1):E1003-7. 8997218
101. Halseth AE Bracy DP Wasserman DH Functional limitations to glucose uptake in muscles comprised of different fiber types Am J Physiol Endocrinol Metab 2001, 280(6):E994-9. 11350781
102. Halseth AE Bracy DP Wasserman DH Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat Am J Physiol Endocrinol Metab 2000, 279(5):E1064-71. 11052961
103. Halseth AE Bracy DP Wasserman DH Limitations to exercise- and maximal insulin-stimulated muscle glucose uptake J Appl Physiol 1998, 85(6):2305-2313. 9843557
104. Petersen HA Fueger PT Bracy DP Wasserman DH Halseth AE Fiber type-specific determinants of Vmax for insulin-stimulated muscle glucose uptake in vivo Am J Physiol Endocrinol Metab 2003, 284(3):E541-8. 12556351
105. O'Doherty RM Halseth AE Granner DK Bracy DP Wasserman DH Analysis of insulin-stimulated skeletal muscle glucose uptake in conscious rat using isotopic glucose analogs Am J Physiol 1998, 274(2 Pt 1):E287-96. 9486160
106. Fiorani M De Sanctis R Saltarelli R Stocchi V Hexokinase inactivation induced by ascorbic acid/Fe(II) in rabbit erythrocytes is independent of glutathione-reductive processes and appears to be mediated by dehydroascorbic acid Arch Biochem Biophys 1997, 342(2):191-196. 10.1006/ abbi.1997.9963 9186478
107. Fiorani M De Sanctis R Scarlatti F Vallorani L De Bellis R Serafini G Bianchi M Stocchi V Dehydroascorbic acid irreversibly inhibits hexokinase activity Mol Cell Biochem 2000, 209(1-2):145-153. 10.1023/ A:1007168032289 10942212
108. Wilden PA Siddle K Haring E Backer JM White MF Kahn CR The role of insulin receptor kinase domain autophosphorylation in receptor-mediated activities. Analysis with insulin and anti-receptor antibodies J Biol Chem 1992, 267(19):13719-13727. 1320027
109. Kanai F Ito K Todaka M Hayashi H Kamohara S Ishii K Okada T Hazeki O Ui M Ebina Y Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase Biochem Biophys Res Commun 1993, 195(2):762-768. 10.1006/bbrc.1993.2111 8396927
110. Moran A Steffen LM Jacobs DR Jr Steinberger J Pankow JS Hong CP Tracy RP Sinaiko AR Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth Diabetes Care 2005, 28(7):1763-1768. 10.2337/diacare.28.7.1763 15983332
111. Curran JE Jowett JB Elliott KS Gao Y Gluschenko K Wang J Abel Azim DM Cai G Mahaney MC Comuzzie AG Dyer TD Walder KR Zimmet P MacCluer JW Collier GR Kissebah AH Blangero J Genetic variation in selenoprotein S influences inflammatory response Nat Genet 2005, 37(11):1234-1241. 10.1038/ng1655 16227999
112. Onengut-Gumuscu S Buckner JH Concannon P A haplotype-based analysis of the PTPN22 locus in type 1 diabetes Diabetes 2006, 55(10):2883-2889. 10.2337/db06-0225 17003357
113. Onengut-Gumuscu S Ewens KG Spielman RS Concannon P A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families Genes Immun 2004, 5(8):678-680. 10.1038/sj.gene.6364138 15526003
114. Zheng W She JX Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes Diabetes 2005, 54(3):906-908. 10.2337/diabetes.54.3.906 15734872
115. Muller S Martin S Koenig W Hanifi-Moghaddam P Rathmann W Haastert B Giani G Illig T Thorand B Kolb H Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors Diabetologia 2002, 45:805-812. 12107724 10.1007/s00125-002-0829-2
116. Busquets S Figueras M Almendro V Lopez-Soriano FJ Argiles JM Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine Biochim Biophys Acta 2006, 1760(11):1613-1617. 17056184
117. Zhang YF Yang YS Hong J Gu WQ Shen CF Xu M Du PF Li XY Ning G Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome Endocrine 2006, 29(3):419-423. 10.1385/ENDO:29:3:419 16943580
118. Fischer CP Perstrup LB Berntsen A Eskildsen P Pedersen BK Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans Clin Immunol 2005, 117(2):152-160. 10.1016/j.clim.2005.07.008 16112617
119. Anhe GF Torrao AS Nogueira TC Caperuto LC Amaral ME Medina MC Azevedo-Martins AK Carpinelli AR Carvalho CR Curi R Boschero AC Bordin S ERK3 associates with MAP2 and is involved in glucose-induced insulin secretion Mol Cell Endocrinol 2006, 251(1-2):33-41. 10.1016/ j.mce.2006.02.012 16597486
120. Bouzakri K Zierath JR MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance J Biol Chem 2007, 282(11):7783-7789. 10.1074/jbc.M608602200 17227768
121. Tang X Guilherme A Chakladar A Powelka AM Konda S Virbasius JV Nicoloro SM Straubhaar J Czech MP An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport Proc Natl Acad Sci USA 2006, 103:2087-2092. 16461467 10.1073/pnas.0507660103 1413698
122. Matter CM Handschin C RANTES (regulated on activation, normal T cell expressed and secreted), inflammation, obesity, and the metabolic syndrome Circulation 2007, 115(2):946-948. 10.1161/ CIRCULATIONAHA.106.685230 17325252
123. Weisberg SP Hunter D Huber R Lemieux J Slaymaker S Vaddi K Charo I Leibel RL Ferrante AW Jr CCR2 modulates inflammatory and metabolic effects of high-fat feeding J Clin Invest 2006, 116(1):115-124. 10.1172/ JCI24335 16341265 1307559
124. de Silva E Stumpf MP HIV and the CCR5-Delta32 resistance allele FEMS Microbiol Lett 2004, 241:1-12. 15556703 10.1016/j.femsle.2004.09.040
125. Carnesecchi S Carpentier JL Foti M Szanto I Insulin-induced vascular endothelial growth factor expression is mediated by the NADPH oxidase NOX3 Exp Cell Res 2006, 312(17):3413-3424. 10.1016/j.yexcr.2006.07.003 16949073
126. Mahadev K Motoshima H Wu X Ruddy JM Arnold RS Cheng G Lambeth JD Goldstein BJ The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction Mol Cell Biol 2004, 24:1844-1854. 14966267 10.1128/MCB.24.5.1844-1854.2004 350558
127. Konheim YL Wolford JK Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians Hum Genet 2003, 113:377-381. 12920574 10.1007/s00439-003-1000-y
128. Kaaman M Ryden M Axelsson T Nordstrom E Sicard A Bouloumie A Langin D Arner P Dahlman I ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance Int J Obes (Lond) 2006, 30:447-452. 16261187 10.1038/sj.ijo.0803147
129. Ohtoshi K Yamasaki Y Gorogawa S Hayaishi-Okano R Node K Matsuhisa M Kajimoto Y Hori M Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance Diabetologia 2002, 45(11):1594-1601. 10.1007/s00125-002-0922-6 12436344
130. Perreault M Marette A Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle Nat Med 2001, 7(10):1138-1143. 10.1038/nm1001-1138 11590438
131. Tsuchiyama N Takamura T Ando H Sakurai M Shimizu A Kato K Kurita S Kaneko S Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes Diabetes Care 2007, 30(10):2583-2587. 10.2337/dc07-0066 17644622
132. Labonte ED Kirby RJ Schildmeyer NM Cannon AM Huggins KW Hui DY Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia Diabetes 2006, 55(4):935-941. 10.2337/diabetes.55.04.06.db05-1286 16567514 2048981
133. Ensemble http://www.ensembl.org